Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.

Much to the consternation of parents, teachers and cruise ship enthusiasts, there are no approved treatments ... furthest along is Moderna, which has developed a norovirus vaccine with the same ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

including an extensive pipeline of therapeutics in clinical trials that could be the booster shot the stock needs to generate a rebound. Let's discuss the pros and cons of buying Moderna stock.

Germany's health ministry has said it will start offering booster COVID-19 vaccines ... The European Medicines Agency has approved the Pfizer/BioNTech and Moderna shots for all over-12s.